Lebanon, July 2013 Cancer medicines
|
Originator brand medicines surveyed Lebanon, July 2013 Cancer medicines
|
|
||||||
| Medicine name | Strength | Dosage form | Medicine list | EML | Originator brand name | Originator brand manufacturer | International reference price source MSH2012 (US $) |
| Anastrozole | 1 mg | cap/tab | Supplementary | No | Arimidex | AstraZeneca | 0.8106 |
| Capecitabine | 500 mg | cap/tab | Supplementary | No | Xeloda | Roche | 2.9528 |
| Docetaxel | 20 mg | vial | Supplementary | No | Taxotere | Aventis | 41.4762 |
| Doxorubicin HCL | 10 mg | vial | Supplementary | No | Adriblastina | Pharmacia | 2.6200 |
| Gemcitabine | 200 mg | vial | Supplementary | No | Gemzar | Lilly | 9.8800 |
| Oxaliplatin | 50 mg | vial | Supplementary | No | Eloxatin | Aventis | 74.8650 |